Skip to main content
. 2022 Dec 10;27(24):8765. doi: 10.3390/molecules27248765

Figure 7.

Figure 7

Binding interaction of compound 4a (A) and reference compound Erlotinib (B) in the ATP binding cavity of EGFR kinase domain.